1. Home
  2. OSCR vs CRSP Comparison

OSCR vs CRSP Comparison

Compare OSCR & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oscar Health Inc.

OSCR

Oscar Health Inc.

HOLD

Current Price

$11.49

Market Cap

3.8B

Sector

Finance

ML Signal

HOLD

Logo CRISPR Therapeutics AG

CRSP

CRISPR Therapeutics AG

HOLD

Current Price

$47.54

Market Cap

4.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSCR
CRSP
Founded
2012
2013
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Accident &Health Insurance
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
4.4B
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
OSCR
CRSP
Price
$11.49
$47.54
Analyst Decision
Hold
Buy
Analyst Count
7
17
Target Price
$17.00
$70.29
AVG Volume (30 Days)
5.8M
1.9M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,701,427,000.00
$289,590,000.00
Revenue This Year
$63.73
$1,082.59
Revenue Next Year
$5.40
$87.74
P/E Ratio
N/A
N/A
Revenue Growth
27.50
9169.85
52 Week Low
$10.69
$30.06
52 Week High
$23.80
$78.48

Technical Indicators

Market Signals
Indicator
OSCR
CRSP
Relative Strength Index (RSI) 37.24 43.87
Support Level N/A $45.53
Resistance Level $15.56 $60.63
Average True Range (ATR) 0.63 1.95
MACD -0.18 -0.27
Stochastic Oscillator 25.60 52.97

Price Performance

Historical Comparison
OSCR
CRSP

About OSCR Oscar Health Inc.

Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: